Status:
COMPLETED
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
Lead Sponsor:
St. Luke's-Roosevelt Hospital Center
Conditions:
Agitation
Anesthesia
Eligibility:
All Genders
6-17 years
Phase:
PHASE3
Brief Summary
Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo...
Detailed Description
Emergence delirium from general anesthesia is a common problem in the pediatric population with a reported incidence of up to 80%. In addition to being jarring to children and their parents, ED can ca...
Eligibility Criteria
Inclusion
- Children age 6 months through 17 years of age undergoing interventional neuroradiologic procedures at our hospital under general anesthesia
- Patients classify as an ASA (American Society of Anesthesiologists) I-III
- Have not received anesthetic for over 30 days from previous procedures
Exclusion
- Receiving digoxin therapy from the study
- Severe congestive heart failure or pulmonary hypertension requiring vasodilators
- Disease processes other than that associated with their intracranial pathology, such as hepatic or renal dysfunction
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00857727
Start Date
August 1 2009
End Date
December 1 2011
Last Update
November 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Luke's-Roosevelt Hospital Center
New York, New York, United States, 10019